Shankar Siva
Experienced in Neuroendocrine Tumor

Shankar Siva

305 Grattan St, 
Melbourne, VIC, AU 
Experienced in Neuroendocrine Tumor
305 Grattan St, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Shankar Siva practices in Melbourne, Australia. Mr. Siva is rated as an Experienced expert by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Renal Cell Carcinoma (RCC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostatectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 337 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Neuroendocrine Tumor.

Gender
Male

Locations

305 Grattan St, Melbourne, VIC 3000, Australia
Other Locations
Locked Bag 5m A'Beckett St, Melbourne, VIC 8006, Australia
St Andrews Place, East Melbourne, VIC 3002, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Radiation
Study Phase: Phase 2
High Intensity Functional Image Guided Vmat Lung Evasion
High Intensity Functional Image Guided Vmat Lung Evasion
Enrollment Status: Completed
Publish Date: May 19, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial
Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial
Enrollment Status: Completed
Publish Date: November 04, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
A Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475.
A Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475.
Enrollment Status: Completed
Publish Date: October 18, 2017
Intervention Type: Radiation, Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

337 Total Publications

Erratum: Sharper Focus, Greater Comfort? Lessons From the ROBOMET Trial.
Erratum: Sharper Focus, Greater Comfort? Lessons From the ROBOMET Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Siva's expertise for a condition
ConditionClose
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile